XTX Topco’s MIRA Pharmaceuticals MIRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5K Sell
16,374
-21,199
-56% -$21.4K ﹤0.01% 3954
2026
Q1
$40.2K Buy
37,573
+16,669
+80% +$20.9K ﹤0.01% 3378
2025
Q4
$31.6K Sell
20,904
-15,019
-42% -$22.1K ﹤0.01% 2952
2025
Q3
$48.9K Buy
35,923
+14,050
+64% +$20.4K ﹤0.01% 2176
2025
Q2
$26.5K Buy
+21,873
New +$25.3K ﹤0.01% 2126
2024
Q2
Sell
-25,544
Closed -$28.1K 2235
2024
Q1
$28.1K Buy
+25,544
New +$27.7K ﹤0.01% 1563

Other funds holding MIRA

XTX Topco's MIRA Position: Q2 2026 in Review

XTX Topco reduced its MIRA Pharmaceuticals (MIRA) stake by 56% in Q2 2026, selling an estimated $21.4K and leaving 16,374 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3954.

XTX Topco first reported a position in MIRA in Q1 2024 and has held it in 6 quarters since. The position peaked at $48.9K in Q3 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • XTX Topco held 16,374 shares of MIRA Pharmaceuticals worth $15.5K as of Q2 2026.
  • XTX Topco sold 21,199 MIRA Pharmaceuticals shares in Q2 2026, an estimated $21.4K.
  • MIRA Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3954 holding.
  • XTX Topco first reported a position in MIRA Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
  • XTX Topco's MIRA Pharmaceuticals position peaked at $48.9K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.